← Back to all trials
Enrolling By Invitation
NCT02422875
Comparative Autoantibody and Immunologic Cell Marker Study
Conditions: Autoimmune Diseases, Lupus Erythematosus, Systemic, Communicable Diseases
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Enrollment: 2500
Sponsor: Emory University
Location: Emory University Hospital Atlanta Georgia
Summary
The purpose of this study is to compare immune phenotype, function, and specificity of B lymphocytes from different developmental stages in autoimmune patients to B cells from infectious disease patients and healthy controls.
Eligibility Criteria
Inclusion Criteria:
* Signed written informed consent by the subject or, if the subject is unable to provide informed consent, the subject's legal representative may provide consent.
* Subjects can be of either gender
* Subjects with autoimmune diseases, and Systemic Lupus Erythematosus (SLE) patients will fulfill the American College of Rheumatology Classification criteria for SLE to be determined by their treating physician but may have incomplete criteria (\
Source: ClinicalTrials.gov (NCT02422875). StuddyBuddy aggregates publicly available trial information.
